Posted by Jeff Daas on Dec 24th, 2009 | no comments
The ability to make, test, and map the atomic structure of new anti-cancer agents has enabled a team of Dana-Farber Cancer Institute scientists to discover a compound capable of halting a common type of drug-resistant lung cancer… Read Full Article